KOSMETISK KLINIK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.0% 5.7% 7.2% 7.1% 7.8%  
Credit score (0-100)  45 42 33 32 31  
Credit rating  BBB BBB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Gross profit  32.8 65.8 7.6 -81.7 -88.8  
EBITDA  36.7 65.7 1.8 -81.7 -88.8  
EBIT  -66.5 -75.0 -153 -263 -270  
Pre-tax profit (PTP)  -61.0 -80.5 -158.0 -271.1 -281.9  
Net earnings  -47.6 -62.8 -123.2 -211.5 -219.9  
Pre-tax profit without non-rec. items  -61.0 -80.5 -158 -271 -282  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  723 669 859 678 496  
Shareholders equity total  755 693 569 358 138  
Interest-bearing liabilities  271 117 389 392 449  
Balance sheet total (assets)  1,149 920 1,068 859 677  

Net Debt  73.7 16.2 353 392 446  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  32.8 65.8 7.6 -81.7 -88.8  
Gross profit growth  -87.8% 100.9% -88.4% 0.0% -8.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,149 920 1,068 859 677  
Balance sheet change%  21.1% -19.9% 16.2% -19.6% -21.2%  
Added value  36.7 65.7 1.8 -107.8 -88.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  137 -195 35 -363 -363  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -203.0% -114.0% -2,009.5% 322.0% 304.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -5.8% -7.3% -15.4% -27.3% -35.2%  
ROI %  -6.1% -7.4% -15.8% -28.1% -36.9%  
ROE %  -6.1% -8.7% -19.5% -45.6% -88.7%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  65.8% 75.3% 53.3% 41.7% 20.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  200.8% 24.7% 20,097.7% -479.8% -502.3%  
Gearing %  35.9% 16.8% 68.4% 109.5% 325.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.2% 2.8% 1.8% 2.1% 2.8%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  1.0 0.8 0.2 0.1 0.1  
Current Ratio  1.0 0.8 0.2 0.1 0.1  
Cash and cash equivalent  197.3 100.5 36.4 0.0 2.9  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1.6 -22.5 -337.2 -382.2 -441.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0